New fillers aim to smooth wrinkles and restore volume – study underway
NCT ID NCT07160777
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing hyaluronic acid dermal fillers to see if they safely improve facial aging signs like wrinkles, volume loss, and lip shape. 80 healthy adults are receiving injections in areas like the cheeks, lips, and around the mouth. Researchers will measure aesthetic improvement and satisfaction over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hyaluronic acid dermal fillers (Semical Dermal Filler Fine, Plus, Ultra, and Mesolifter)
- What this could lead to
- If successful, this could confirm that these fillers safely improve facial wrinkles, volume loss, and lip appearance.
- What could go wrong
- This is a single-center study with 80 people, so results may not apply to everyone. Fillers can cause temporary swelling, bruising, or rare complications like infection or lumps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akdeniz University Hospital Dermatology Department Cosmetology Clinic
Antalya, 07100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can different fillers turn back the clock on facial aging?
- Face-Lift without surgery? fat transfer may turn back the clock on wrinkles
- Your face may hold the key to your true age — AI decodes it
- Acupuncture needles vs. wrinkles: one session may boost skin thickness
- Botox battle: which injection site lifts drooping mouth corners best?
- Ultrasound eyebrow lift shows promise in clinical trial